期刊
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
卷 18, 期 4, 页码 1171-1173出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/jcrt.JCRT_802_19
关键词
68Ga-DOTATOC positron-emission tomography; computed tomography; desmoid tumor; mesenteric fibromatosis; neuroendocrine tumor; somatostatin receptor
类别
Mesenteric fibromatosis is a locally aggressive fibroblastic lesion with a high recurrence rate. This study found that the tumor cells express somatostatin receptors and suggested that it could be one of the potential causes of false-positive results in 68Ga PET/CT.
Mesenteric fibromatosis (desmoid tumor) is a locally aggressive fibroblastic lesion, characterized by a high recurrence rate that makes treatment challenging. Currently, there is no evidence-based treatment approach. We report the case of a female patient with a history of neuroendocrine tumor, who underwent( 68)Ga-DOTATOC positron-emission tomography/computed tomography (PET/CT), showing increased focal abdominal uptake suggestive of disease relapse. Histological examination revealed typical findings of fibromatosis. These findings indicate the expression of staining for somatostatin receptors (SSTRs) on fibromatosis cell surface and suggest to include fibromatosis among the potential causes of false-positive results at 68Ga PET/CT. Moreover, SSTRs expressed in desmoid tumors could be further investigated as a therapeutic target.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据